🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Phase I, open-label study to assess the safety, feasibility, pharmacokineti...
Status
Active Not Recruiting
Location
University of Pennsylvania
Start Date
2025-02-28
Trial ID
NCT06768476
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficiency of CD123...
Status
Unknown
Location
307 Hospital of PLA
Start Date
2018-03-01
Trial ID
NCT03556982
Treatments Being Tested
Phase 1 open-label study to evaluate the safety of intravenously administer...
Status
Terminated
Location
Children's Hospital of Philadelphia
Start Date
2021-04-02
Trial ID
NCT04678336
Treatments Being Tested
Pilot open-label study to estimate the feasibility, safety and efficacy of ...
Status
Terminated
Location
Abramson Cancer Center of the University of Pennsylvania
Start Date
2015-12
Trial ID
NCT02623582
Treatments Being Tested
This study is designed to evaluate the safety and effectiveness of CART123 ...
Status
Recruiting
Location
Children's Hospital of Philadelphia
Start Date
2026-05-14
Trial ID
NCT07464951
Treatments Being Tested
Adult patients with refractory or relapsed CD123+ hematologic malignancies,...
Status
Recruiting
Location
Ustav hematologie a krevni transfuze / Institute of Hematology and Blood Transfusion
Start Date
2024-10-23
Trial ID
NCT06765876
Treatments Being Tested
Phase 1 open-label study to estimate the safety, manufacturing feasibility,...
Status
Terminated
Location
University of Pennsylvania
Start Date
2018-12-06
Trial ID
NCT03766126
Treatments Being Tested
Patients with acute myeloid leukemia(AML) recurred after the allogeneic hem...
Status
Unknown
Location
Fengtai District
Start Date
2017-03-25
Trial ID
NCT03114670
Treatments Being Tested